CD44 and breast neoplasm: The complex formation of glycoprotein CD44 and its ligand MMP-9 on the cell surface of breast tumor cells was found to promote ECM degradation, cell migration, invasion and metastasis, suggesting that the MMP-9/CD44 axis is a promising therapeutic target [30].